AMGN compared with PCVX: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

PCVXVaxcyte, Inc.

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

PCVXVaxcyte, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

461.49▼−3.55%· post 460.22

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

PCVXVaxcyte, Inc.

61.92▼−5.72%· post 61.35

ClosedNov 5 '26

Mkt cap$10.4BRevenue—Revenue—

Compare

ClosedNov 5 '26

AMGNAmgen Inc

PCVXVaxcyte, Inc.

461.49▼−3.55%post 460.22

Price

61.92▼−5.72%post 61.35

$249.0B

Mkt cap

$10.4B

Q3 FY26$10.4B

Revenue

—

FY25$36.8B

Revenue

—

AMGN461.49▼−3.55%vsPCVX61.92▼−5.72%ClosedNov 5 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PCVX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only PCVX 4

TMOPatheon Manufacturing Services LLC, part of Thermo Fisher Scientific (collectively, "Thermo Fisher")supplier

—Lonzaunlistedsupplier

—Sutro Biopharmaunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

University of California, San Diego

unlistedsupplier

Price

rebased to 0%

AMGN, solidPCVX, dashed